+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vitamin B3 Market - Global Forecast 2026-2032- Product Image
Vitamin B3 Market - Global Forecast 2026-2032- Product Image
New

Vitamin B3 Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 199 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5612777
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Vitamin B3 Market grew from USD 413.89 million in 2025 to USD 441.86 million in 2026. It is expected to continue growing at a CAGR of 5.60%, reaching USD 606.28 million by 2032.

Comprehensive orientation to vitamin B3’s chemical profiles, formulation considerations, regulatory context, and cross-sector relevance for strategic decision-makers

Vitamin B3 occupies a central position in nutrition science, pharmaceutical formulation, and personal care innovation due to its multifaceted biochemical roles and broad applicability. The introduction establishes the nutrient’s fundamental chemistry, clarifies commonly used commercial variants such as niacin and niacinamide, and differentiates their sensory, functional, and stability characteristics that influence formulation choices across product categories.

Moving beyond chemistry, the consumer and industrial drivers that determine demand are explored. In nutritional supplements, efficacy narratives and regulatory frameworks shape label claims and ingredient selection. In pharmaceuticals and medical nutrition, therapeutic positioning and delivery formats influence manufacturing approaches. Meanwhile, in personal care and fortified foods, sensory compatibility and clean-label preferences have become decisive. Together, these intersecting dynamics set the stage for how value is created and captured across the value chain, and they establish the baseline for deeper strategic considerations throughout the remainder of this summary.

How shifting consumer preferences, regulatory scrutiny, and manufacturing innovations are jointly reshaping product positioning, supply dynamics, and go-to-market strategies

The vitamin B3 landscape has experienced transformative shifts driven by evolving consumer expectations, regulatory tightening, and technological advances in ingredient production. Over recent years, the rise of clean-label and functional wellness narratives has accelerated product innovation, prompting formulators to prioritize variants that balance bioavailability with sensory neutrality. Concurrently, downstream channels such as direct-to-consumer e-commerce and specialty food retailers have altered how new formulations are launched and iterated, shortening the feedback loop and increasing the premium placed on speed to market.

In parallel, manufacturing technology and synthesis methods have matured, enabling greater control over impurity profiles and offering pathways to more sustainable production. As a consequence, product positioning is increasingly determined by origin story and process transparency, while regulatory scrutiny of claims and ingredient quality has grown. These shifts mean that companies that integrate differentiation through quality control, transparent sourcing, and targeted consumer communication gain a competitive edge, and they must continually align R&D, regulatory affairs, and marketing to capitalize on evolving opportunities.

Implications of recent United States tariff measures on sourcing strategies, supply-chain resilience, and manufacturing location decisions across the vitamin B3 value chain

In 2025, tariffs and trade policies originating from the United States have compounded cost and logistical considerations for many participants in the vitamin B3 value chain, altering supplier selection criteria and inventory strategies. Import duties have intensified attention on regional sourcing options and have encouraged firms to reassess long-term supplier agreements, desiring greater geographic diversification as a hedge against policy volatility. Consequently, procurement teams are prioritizing supplier resilience, quality certification parity, and nearshoring where feasible to preserve continuity of supply and consistent quality standards.

Moreover, the tariff environment has influenced product development priorities by increasing the attractiveness of localized production for high-value or highly regulated dosage forms, including pharmaceuticals and medical nutrition. Regulatory compliance costs and lead-time uncertainties have led to more conservative inventory policies for critical intermediates, while at the same time accelerating investment in supplier qualification and dual-sourcing programs. For companies with integrated manufacturing footprints, the response has been to enhance cross-border logistics planning and to use contractual safeguards and hedging mechanisms to stabilize input costs in the face of policy-driven disruption.

Deep segmentation-driven insights that link application needs, molecular types, formulation forms, source origins, and distribution pathways to commercial and regulatory priorities

Segmentation analysis reveals how therapeutic intent, formulation science, and channel economics generate differentiated demand pockets and margin profiles. When examining the market through the lens of application, important distinctions emerge between animal feed needs for livestock categories such as cattle, poultry, and swine, and human-focused formats like dietary supplements that range from multivitamin blends to single vitamin B3 products. Food and beverage uses such as fortified dairy, fortified water, and functional beverages impose sensory and stability constraints that differ markedly from personal care and cosmetics applications, which include cosmetics, creams and lotions, and serums; pharmaceuticals demand stringent delivery formats such as capsules, injectables, and tablets that prioritize purity and pharmacokinetics.

Type-level segmentation underscores functional differentiation between inositol hexanicotinate, niacin, and niacinamide and their respective physical presentations. For example, certain ester forms are selected for perceived tolerability, while crystal and powder forms of niacin dictate different dissolution and blending behaviors. Form-oriented distinctions between capsules, liquid suspensions or syrups, powders that may be granulated or microfine, and tablets that can be coated or uncoated reveal manufacturing and stability trade-offs that drive process selection. Source-based segmentation highlights choices among animal-derived inputs such as fish meal and liver extract, plant-derived feedstocks like corn, soybean, and wheat, and fully synthetic chemical synthesis routes, each of which carries implications for traceability, allergen management, and sustainability claims. Distribution channel differences across food specialty stores, hospital pharmacies, online direct-to-consumer and e-commerce platforms, and retail pharmacies-both chain and independent-further shape assortment strategies, promotional cadence, and inventory planning. Together, these intersecting segmentation lenses guide product development priorities and inform targeted commercialization strategies.

Regional strategic imperatives driven by divergent regulatory frameworks, consumer expectations, and manufacturing concentrations across major global markets

Regional dynamics introduce varied regulatory regimes, consumption patterns, and supply-chain architectures that require distinct commercial playbooks. In the Americas, consumer interest in performance nutrition and clinically supported supplement claims tends to favor evidence-backed formulations and value propositions centered on efficacy, while distribution channels combine large retail pharmacy chains with a vibrant e-commerce landscape that rewards direct consumer engagement. In Europe, Middle East & Africa, a mosaic of regulatory approaches and trade agreements requires careful label claim management and strengthens the importance of certified quality and provenance, especially for export-oriented manufacturers and brands seeking regulatory harmonization across diverse markets.

Meanwhile, the Asia-Pacific region is characterized by dynamic manufacturing capacity and a dense supplier ecosystem, paired with rapidly evolving consumer preferences that blend traditional wellness concepts with modern functional positioning. These regional differences mean that companies must tailor sourcing strategies, regulatory dossiers, and marketing narratives to local expectations, and they must invest in regional regulatory intelligence and partner networks to accelerate approvals and commercial rollouts. Cross-border collaboration and targeted local investments therefore become central to any effective international expansion strategy.

Competitive and corporate capability insights emphasizing quality systems, formulation partnerships, and provenance-driven differentiation across the value chain

Competitive activity in the vitamin B3 space is driven by capabilities in high-purity production, regulatory compliance, and downstream customer engagement. Leaders differentiate through investments in process controls that reduce impurity profiles, comprehensive quality management systems that support therapeutic and nutraceutical applications, and technical service teams that co-develop formulations with customers. In addition, firms that establish transparent sourcing narratives and traceability systems tend to win shelf space and premium positioning in channels where provenance matters to consumers and procurement partners alike.

Strategic partnerships, contract manufacturing relationships, and specialized distribution agreements are common avenues for scaling commercial reach and meeting complex customer specifications. Equally important are capabilities in application development and claim substantiation, which enable suppliers and brands to convert scientific attributes into compelling product stories for healthcare professionals and direct consumers. As environmental, social, and governance expectations intensify, companies that can demonstrate reductions in process waste, energy use, and a credible plan for sustainable sourcing will be better positioned to meet both customer requirements and regulatory scrutiny.

Actionable and integrated strategic measures to strengthen supply resilience, accelerate differentiated product development, and align commercialization with high-value channels

For industry leaders seeking to convert insight into advantage, a set of pragmatic actions can sharpen competitiveness and reduce exposure to external shocks. First, prioritize supplier diversification and qualification programs that encompass both alternative geographic sources and synthetic versus bio-derived routes to balance cost, quality, and regulatory risk. Second, accelerate product differentiation through investments in formulation science and clinical or functional validation so that claims are supported by reproducible data and clear consumer benefits. Third, align commercialization strategies to channel-specific requirements by tailoring packaging, claims, and logistics for specialty retailers, hospital procurement, online platforms, and pharmacy chains.

In addition, integrate regulatory intelligence into early-stage R&D decision-making to avoid costly reformulation cycles and to speed time to shelf in complex jurisdictions. Finally, strengthen contractual and operational hedges against trade policy shifts by utilizing dual-sourcing, strategic inventory buffers for critical intermediates, and closer collaboration between procurement, legal, and finance teams to manage tariff exposure. By executing these measures in an integrated manner, organizations can both protect margins and create sustained differentiation in a competitive environment.

Methodology combining primary stakeholder interviews, regulatory and technical literature synthesis, and cross-functional triangulation to generate decision-focused insights

The research methodology underpinning this analysis draws on a mixed-methods approach that balances primary stakeholder engagement with secondary validation to produce robust, actionable insights. Primary inputs include structured interviews with formulators, procurement leads, channel managers, and regulatory specialists to surface practical constraints and decision heuristics that govern product selection and sourcing choices. These qualitative insights were triangulated with publicly available regulatory texts, industry guidance documents, and technical literature on vitamin biochemistry and formulation behavior to validate assumptions and contextualize observed market dynamics.

Analytical rigor was ensured through cross-functional review and synthesis, with special attention to supply-chain mapping, segmentation alignment, and scenario analysis of policy impacts. Wherever possible, the methodology favored corroboration from multiple independent sources, and it emphasized relevance to commercial decision-making by translating technical findings into strategic implications for product developers, procurement teams, and senior management.

Synthesis of strategic priorities highlighting quality, regulatory alignment, and resilient commercialization as the pathway to sustained competitive advantage

The vitamin B3 landscape presents a blend of enduring scientific relevance and shifting commercial realities that demand proactive, integrated responses from market participants. Persistent demand across animal nutrition, human supplements, food fortification, personal care, and pharmaceuticals ensures that technical excellence and regulatory compliance remain the twin pillars of competitive advantage. At the same time, trade policy volatility and evolving consumer expectations around provenance and sustainability are reshaping procurement, product development, and go-to-market strategies.

In sum, success will accrue to organizations that can align high-quality production with credible claims, adapt distribution approaches to channel-specific dynamics, and invest in supplier resilience to weather policy and logistical disruption. By combining rigorous quality systems, targeted innovation, and strategic commercial execution, firms can convert current challenges into long-term competitive differentiation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Vitamin B3 Market, by Type
8.1. Niacin
8.1.1. Crystal
8.1.2. Powder
8.2. Niacinamide
8.2.1. Granular
8.2.2. Powder
9. Vitamin B3 Market, by Form
9.1. Capsule
9.1.1. Hard
9.1.2. Soft
9.2. Liquid
9.2.1. Suspension
9.2.2. Syrup
9.3. Powder
9.3.1. Granulated
9.3.2. Microfine
9.4. Tablet
9.4.1. Coated
9.4.2. Uncoated
10. Vitamin B3 Market, by Source
10.1. Animal
10.1.1. Fish Meal
10.1.2. Liver Extract
10.2. Plant
10.2.1. Corn
10.2.2. Soybean
10.2.3. Wheat
11. Vitamin B3 Market, by Application
11.1. Animal Feed
11.1.1. Cattle
11.1.2. Poultry
11.1.3. Swine
11.2. Dietary Supplements
11.2.1. Multivitamin Blend
11.2.2. Single Vitamin B3 Products
11.3. Food & Beverage
11.3.1. Fortified Dairy
11.3.2. Fortified Water
11.3.3. Functional Beverages
11.4. Personal Care & Cosmetics
11.4.1. Cosmetics
11.4.2. Creams & Lotions
11.4.3. Serums
11.5. Pharmaceuticals
11.5.1. Capsules
11.5.2. Injectables
11.5.3. Tablets
12. Vitamin B3 Market, by Distribution Channel
12.1. Food Specialty Store
12.1.1. Health Food Stores
12.1.2. Supermarket Specialty Aisles
12.2. Hospital Pharmacy
12.2.1. Government Hospital
12.2.2. Private Hospital
12.3. Online
12.3.1. Direct-To-Consumer
12.3.2. E-Commerce Platforms
12.4. Retail Pharmacy
12.4.1. Chain Pharmacy
12.4.2. Independent Pharmacy
13. Vitamin B3 Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Vitamin B3 Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Vitamin B3 Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Vitamin B3 Market
17. China Vitamin B3 Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Adisseo France S.A.S.
18.6. Anhui Redpont Biotechnology Co., Ltd.
18.7. Archer-Daniels-Midland Company
18.8. BASF SE
18.9. Brother Enterprises Holding Co., Ltd.
18.10. Hefei TNJ Chemical Co., Ltd.
18.11. Jubilant Life Sciences Limited
18.12. Koninklijke DSM N.V.
18.13. Lonza Group AG
18.14. Shandong Binode Biopharma Co., Ltd.
18.15. Shandong Wosi Biotech Co., Ltd.
18.16. Zhejiang NHU Co., Ltd.
List of Figures
FIGURE 1. GLOBAL VITAMIN B3 MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL VITAMIN B3 MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL VITAMIN B3 MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL VITAMIN B3 MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL VITAMIN B3 MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL VITAMIN B3 MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL VITAMIN B3 MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VITAMIN B3 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL VITAMIN B3 MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VITAMIN B3 MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL VITAMIN B3 MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES VITAMIN B3 MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA VITAMIN B3 MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL VITAMIN B3 MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL VITAMIN B3 MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL VITAMIN B3 MARKET SIZE, BY NIACIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL VITAMIN B3 MARKET SIZE, BY NIACIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL VITAMIN B3 MARKET SIZE, BY NIACIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL VITAMIN B3 MARKET SIZE, BY NIACIN, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL VITAMIN B3 MARKET SIZE, BY CRYSTAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL VITAMIN B3 MARKET SIZE, BY CRYSTAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL VITAMIN B3 MARKET SIZE, BY CRYSTAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL VITAMIN B3 MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL VITAMIN B3 MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL VITAMIN B3 MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL VITAMIN B3 MARKET SIZE, BY NIACINAMIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL VITAMIN B3 MARKET SIZE, BY NIACINAMIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL VITAMIN B3 MARKET SIZE, BY NIACINAMIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL VITAMIN B3 MARKET SIZE, BY NIACINAMIDE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL VITAMIN B3 MARKET SIZE, BY GRANULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL VITAMIN B3 MARKET SIZE, BY GRANULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL VITAMIN B3 MARKET SIZE, BY GRANULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL VITAMIN B3 MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL VITAMIN B3 MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL VITAMIN B3 MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL VITAMIN B3 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL VITAMIN B3 MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL VITAMIN B3 MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL VITAMIN B3 MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL VITAMIN B3 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL VITAMIN B3 MARKET SIZE, BY HARD, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL VITAMIN B3 MARKET SIZE, BY HARD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL VITAMIN B3 MARKET SIZE, BY HARD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL VITAMIN B3 MARKET SIZE, BY SOFT, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL VITAMIN B3 MARKET SIZE, BY SOFT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL VITAMIN B3 MARKET SIZE, BY SOFT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL VITAMIN B3 MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL VITAMIN B3 MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL VITAMIN B3 MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL VITAMIN B3 MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL VITAMIN B3 MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL VITAMIN B3 MARKET SIZE, BY SUSPENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL VITAMIN B3 MARKET SIZE, BY SUSPENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL VITAMIN B3 MARKET SIZE, BY SYRUP, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL VITAMIN B3 MARKET SIZE, BY SYRUP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL VITAMIN B3 MARKET SIZE, BY SYRUP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL VITAMIN B3 MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL VITAMIN B3 MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL VITAMIN B3 MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL VITAMIN B3 MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL VITAMIN B3 MARKET SIZE, BY GRANULATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL VITAMIN B3 MARKET SIZE, BY GRANULATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL VITAMIN B3 MARKET SIZE, BY GRANULATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL VITAMIN B3 MARKET SIZE, BY MICROFINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL VITAMIN B3 MARKET SIZE, BY MICROFINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL VITAMIN B3 MARKET SIZE, BY MICROFINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL VITAMIN B3 MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL VITAMIN B3 MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL VITAMIN B3 MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL VITAMIN B3 MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL VITAMIN B3 MARKET SIZE, BY COATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL VITAMIN B3 MARKET SIZE, BY COATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL VITAMIN B3 MARKET SIZE, BY COATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL VITAMIN B3 MARKET SIZE, BY UNCOATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL VITAMIN B3 MARKET SIZE, BY UNCOATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL VITAMIN B3 MARKET SIZE, BY UNCOATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL VITAMIN B3 MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL VITAMIN B3 MARKET SIZE, BY ANIMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL VITAMIN B3 MARKET SIZE, BY ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL VITAMIN B3 MARKET SIZE, BY ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL VITAMIN B3 MARKET SIZE, BY ANIMAL, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL VITAMIN B3 MARKET SIZE, BY FISH MEAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL VITAMIN B3 MARKET SIZE, BY FISH MEAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL VITAMIN B3 MARKET SIZE, BY FISH MEAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL VITAMIN B3 MARKET SIZE, BY LIVER EXTRACT, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL VITAMIN B3 MARKET SIZE, BY LIVER EXTRACT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL VITAMIN B3 MARKET SIZE, BY LIVER EXTRACT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL VITAMIN B3 MARKET SIZE, BY PLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL VITAMIN B3 MARKET SIZE, BY PLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL VITAMIN B3 MARKET SIZE, BY PLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL VITAMIN B3 MARKET SIZE, BY PLANT, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL VITAMIN B3 MARKET SIZE, BY CORN, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL VITAMIN B3 MARKET SIZE, BY CORN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL VITAMIN B3 MARKET SIZE, BY CORN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL VITAMIN B3 MARKET SIZE, BY SOYBEAN, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL VITAMIN B3 MARKET SIZE, BY SOYBEAN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL VITAMIN B3 MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL VITAMIN B3 MARKET SIZE, BY WHEAT, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL VITAMIN B3 MARKET SIZE, BY WHEAT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL VITAMIN B3 MARKET SIZE, BY WHEAT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL VITAMIN B3 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL VITAMIN B3 MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL VITAMIN B3 MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL VITAMIN B3 MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL VITAMIN B3 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL VITAMIN B3 MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL VITAMIN B3 MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL VITAMIN B3 MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL VITAMIN B3 MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL VITAMIN B3 MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL VITAMIN B3 MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL VITAMIN B3 MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL VITAMIN B3 MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL VITAMIN B3 MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL VITAMIN B3 MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL VITAMIN B3 MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL VITAMIN B3 MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL VITAMIN B3 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL VITAMIN B3 MARKET SIZE, BY MULTIVITAMIN BLEND, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL VITAMIN B3 MARKET SIZE, BY MULTIVITAMIN BLEND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL VITAMIN B3 MARKET SIZE, BY MULTIVITAMIN BLEND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL VITAMIN B3 MARKET SIZE, BY SINGLE VITAMIN B3 PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL VITAMIN B3 MARKET SIZE, BY SINGLE VITAMIN B3 PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL VITAMIN B3 MARKET SIZE, BY SINGLE VITAMIN B3 PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL VITAMIN B3 MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL VITAMIN B3 MARKET SIZE, BY FOOD & BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL VITAMIN B3 MARKET SIZE, BY FOOD & BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL VITAMIN B3 MARKET SIZE, BY FOOD & BEVERAGE, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL VITAMIN B3 MARKET SIZE, BY FORTIFIED DAIRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL VITAMIN B3 MARKET SIZE, BY FORTIFIED DAIRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL VITAMIN B3 MARKET SIZE, BY FORTIFIED DAIRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL VITAMIN B3 MARKET SIZE, BY FORTIFIED WATER, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL VITAMIN B3 MARKET SIZE, BY FORTIFIED WATER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL VITAMIN B3 MARKET SIZE, BY FORTIFIED WATER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL VITAMIN B3 MARKET SIZE, BY FUNCTIONAL BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL VITAMIN B3 MARKET SIZE, BY FUNCTIONAL BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL VITAMIN B3 MARKET SIZE, BY FUNCTIONAL BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL VITAMIN B3 MARKET SIZE, BY PERSONAL CARE & COSMETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL VITAMIN B3 MARKET SIZE, BY PERSONAL CARE & COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL VITAMIN B3 MARKET SIZE, BY PERSONAL CARE & COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL VITAMIN B3 MARKET SIZE, BY PERSONAL CARE & COSMETICS, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL VITAMIN B3 MARKET SIZE, BY COSMETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL VITAMIN B3 MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL VITAMIN B3 MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL VITAMIN B3 MARKET SIZE, BY CREAMS & LOTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL VITAMIN B3 MARKET SIZE, BY CREAMS & LOTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL VITAMIN B3 MARKET SIZE, BY CREAMS & LOTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL VITAMIN B3 MARKET SIZE, BY SERUMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL VITAMIN B3 MARKET SIZE, BY SERUMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL VITAMIN B3 MARKET SIZE, BY SERUMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL VITAMIN B3 MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL VITAMIN B3 MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL VITAMIN B3 MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL VITAMIN B3 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL VITAMIN B3 MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL VITAMIN B3 MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL VITAMIN B3 MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL VITAMIN B3 MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL VITAMIN B3 MARKET SIZE, BY INJECTABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL VITAMIN B3 MARKET SIZE, BY INJECTABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL VITAMIN B3 MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL VITAMIN B3 MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL VITAMIN B3 MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL VITAMIN B3 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL VITAMIN B3 MARKET SIZE, BY FOOD SPECIALTY STORE, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL VITAMIN B3 MARKET SIZE, BY FOOD SPECIALTY STORE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL VITAMIN B3 MARKET SIZE, BY FOOD SPECIALTY STORE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL VITAMIN B3 MARKET SIZE, BY FOOD SPECIALTY STORE, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL VITAMIN B3 MARKET SIZE, BY HEALTH FOOD STORES, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL VITAMIN B3 MARKET SIZE, BY HEALTH FOOD STORES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL VITAMIN B3 MARKET SIZE, BY HEALTH FOOD STORES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL VITAMIN B3 MARKET SIZE, BY SUPERMARKET SPECIALTY AISLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL VITAMIN B3 MARKET SIZE, BY SUPERMARKET SPECIALTY AISLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL VITAMIN B3 MARKET SIZE, BY SUPERMARKET SPECIALTY AISLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL VITAMIN B3 MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL VITAMIN B3 MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL VITAMIN B3 MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL VITAMIN B3 MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL VITAMIN B3 MARKET SIZE, BY GOVERNMENT HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL VITAMIN B3 MARKET SIZE, BY GOVERNMENT HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL VITAMIN B3 MARKET SIZE, BY GOVERNMENT HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL VITAMIN B3 MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL VITAMIN B3 MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL VITAMIN B3 MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL VITAMIN B3 MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL VITAMIN B3 MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL VITAMIN B3 MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL VITAMIN B3 MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL VITAMIN B3 MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL VITAMIN B3 MARKET SIZE, BY DIRECT-TO-CONSUMER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL VITAMIN B3 MARKET SIZE, BY DIRECT-TO-CONSUMER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL VITAMIN B3 MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL VITAMIN B3 MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL VITAMIN B3 MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL VITAMIN B3 MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL VITAMIN B3 MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL VITAMIN B3 MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL VITAMIN B3 MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL VITAMIN B3 MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL VITAMIN B3 MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL VITAMIN B3 MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL VITAMIN B3 MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL VITAMIN B3 MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL VITAMIN B3 MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL VITAMIN B3 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 193. AMERICAS VITAMIN B3 MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 194. AMERICAS VITAMIN B3 MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 195. AMERICAS VITAMIN B3 MARKET SIZE, BY NIACIN, 2018-2032 (USD MILLION)
TABLE 196. AMERICAS VITAMIN B3 MARKET SIZE, BY NIACINAMIDE, 2018-2032 (USD MILLION)
TABLE 197. AMERICAS VITAMIN B3 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 198. AMERICAS VITAMIN B3 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 199. AMERICAS VITAMIN B3 MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 200. AMERICAS VITAMIN B3 MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 201. AMERICAS VITAMIN B3 MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 202. AMERICAS VITAMIN B3 MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 203. AMERICAS VITAMIN B3 MARKET SIZE, BY ANIMAL, 2018-2032 (USD MILLION)
TABLE 204. AMERICAS VITAMIN B3 MARKET SIZE, BY PLANT, 2018-2032 (USD MILLION)
TABLE 205. AMERICAS VITAMIN B3 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS VITAMIN B3 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 207. AMERICAS VITAMIN B3 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 208. AMERICAS VITAMIN B3 MARKET SIZE, BY FOOD & BEVERAGE, 2018-2032 (USD MILLION)
TABLE 209. AMERICAS VITAMIN B3 MARKET SIZE, BY PERSONAL CARE & COSMETICS, 2018-2032 (USD MILLION)
TABLE 210. AMERICAS VITAMIN B3 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 211. AMERICAS VITAMIN B3 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 212. AMERICAS VITAMIN B3 MARKET SIZE, BY FOOD SPECIALTY STORE, 2018-2032 (USD MILLION)
TABLE 213. AMERICAS VITAMIN B3 MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 214. AMERICAS VITAMIN B3 MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 215. AMERICAS VITAMIN B3 MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 216. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 218. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY NIACIN, 2018-2032 (USD MILLION)
TABLE 219. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY NIACINAMIDE, 2018-2032 (USD MILLION)
TABLE 220. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 221. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 222. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 224. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY ANIMAL, 2018-2032 (USD MILLION)
TABLE 227. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY PLANT, 2018-2032 (USD MILLION)
TABLE 228. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 229. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY FOOD & BEVERAGE, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY PERSONAL CARE & COSMETICS, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 234. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 235. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY FOOD SPECIALTY STORE, 2018-2032 (USD MILLION)
TABLE 236. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA VITAMIN B3 MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 239. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 241. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY NIACIN, 2018-2032 (USD MILLION)
TABLE 242. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY NIACINAMIDE, 2018-2032 (USD MILLION)
TABLE 243. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 244. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 245. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 246. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 247. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 248. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 249. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY ANIMAL, 2018-2032 (USD MILLION)
TABLE 250. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY PLANT, 2018-2032 (USD MILLION)
TABLE 251. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 253. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 254. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY FOOD & BEVERAGE, 2018-2032 (USD MILLION)
TABLE 255. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY PERSONAL CARE & COSMETICS, 2018-2032 (USD MILLION)
TABLE 256. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 257. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 258. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY FOOD SPECIALTY STORE, 2018-2032 (USD MILLION)
TABLE 259. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 260. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 261. LATIN AMERICA VITAMIN B3 MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY NIACIN, 2018-2032 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY NIACINAMIDE, 2018-2032 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY ANIMAL, 2018-2032 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY PLANT, 2018-2032 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY FOOD & BEVERAGE, 2018-2032 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY PERSONAL CARE & COSMETICS, 2018-2032 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY FOOD SPECIALTY STORE, 2018-2032 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA VITAMIN B3 MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 285. EUROPE VITAMIN B3 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 286. EUROPE VITAMIN B3 MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 287. EUROPE VITAMIN B3 MARKET SIZE, BY NIACIN, 2018-2032 (USD MILLION)
TABLE 288. EUROPE VITAMIN B3 MARKET SIZE, BY NIACINAMIDE, 2018-2032 (USD MILLION)
TABLE 289. EUROPE VITAMIN B3 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 290. EUROPE VITAMIN B3 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 291. EUROPE VITAMIN B3 MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 292. EUROPE VITAMIN B3 MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 293. EUROPE VITAMIN B3 MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 294. EUROPE VITAMIN B3 MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 295. EUROPE VITAMIN B3 MARKET SIZE, BY ANIMAL, 2018-2032 (USD MILLION)
TABLE 296. EUROPE VITAMIN B3 MARKET SIZE, BY PLANT, 2018-2032 (USD MILLION)
TABLE 297. EUROPE VITAMIN B3 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 298. EUROPE VITAMIN B3 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 299. EUROPE VITAMIN B3 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 300. EUROPE VITAMIN B3 MARKET SIZE, BY FOOD & BEVERAGE, 2018-2032 (USD MILLION)
TABLE 301. EUROPE VITAMIN B3 MARKET SIZE, BY PERSONAL CARE & COSMETICS, 2018-2032 (USD MILLION)
TABLE 302. EUROPE VITAMIN B3 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 303. EUROPE VITAMIN B3 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 304. EUROPE VITAMIN B3 MARKET SIZE, BY FOOD SPECIALTY STORE, 2018-2032 (USD MILLION)
TABLE 305. EUROPE VITAMIN B3 MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 306. EUROPE VITAMIN B3 MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 307. EUROPE VITAMIN B3 MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 308. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 309. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 310. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY NIACIN, 2018-2032 (USD MILLION)
TABLE 311. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY NIACINAMIDE, 2018-2032 (USD MILLION)
TABLE 312. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 313. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 314. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 315. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 316. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 317. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 318. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY ANIMAL, 2018-2032 (USD MILLION)
TABLE 319. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY PLANT, 2018-2032 (USD MILLION)
TABLE 320. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 321. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 322. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 323. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY FOOD & BEVERAGE, 2018-2032 (USD MILLION)
TABLE 324. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY PERSONAL CARE & COSMETICS, 2018-2032 (USD MILLION)
TABLE 325. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 326. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 327. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY FOOD SPECIALTY STORE, 2018-2032 (USD MILLION)
TABLE 328. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 329. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 330. MIDDLE EAST VITAMIN B3 MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 331. AFRICA VITAMIN B3 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 332. AFRICA VITAMIN B3 MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 333. AFRICA VITAMIN B3 MARKET SIZE, BY NIACIN, 2018-2032 (USD MILLION)
TABLE 334. AFRICA VITAMIN B3 MARKET SIZE, BY NIACINAMIDE, 2018-2032 (USD MILLION)
TABLE 335. AFRICA VITAMIN B3 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 336. AFRICA VITAMIN B3 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 337. AFRICA VITAMIN B3 MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 338. AFRICA VITAMIN B3 MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 339. AFRICA VITAMIN B3 MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 340. AFRICA VITAMIN B3 MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 341. AFRICA VITAMIN B3 MARKET SIZE, BY ANIMAL, 2018-2032 (USD MILLION)
TABLE 342. AFRICA VITAMIN B3 MARKET SIZE, BY PLANT, 2018-2032 (USD MILLION)
TABLE 343. AFRICA VITAMIN B3 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 344. AFRICA VITAMIN B3 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 345. AFRICA VITAMIN B3 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 346. AFRICA VITAMIN B3 MARKET SIZE, BY FOOD & BEVERAGE, 2018-2032 (USD MILLION)
TABLE 347. AFRICA VITAMIN B3 MARKET SIZE, BY PERSONAL CARE & COSMETICS, 2018-2032 (USD MILLION)
TABLE 348. AFRICA VITAMIN B3 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 349. AFRICA VITAMIN B3 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 350. AFRICA VITAMIN B3 MARKET SIZE, BY FOOD SPECIALTY STORE, 2018-2032 (USD MILLION)
TABLE 351. AFRICA VITAMIN B3 MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2032 (USD MILLION)
TABLE 352. AFRICA VITAMIN B3 MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 353. AFRICA VITAMIN B3 MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
TABLE 354. ASIA-PACIFIC VITAMIN B3 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 355. ASIA-PACIFIC VITAMIN B3 MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 356. ASIA-PACIFIC VITAMIN B3 MARKET SIZE, BY NIACIN, 2018-2032 (USD MILLION)
TABLE 357. ASIA-PACIFIC VITAMIN B3 MARKET SIZE, BY NIACINAMIDE, 2018-2032 (USD MILLION)
TABLE 358. ASIA-PACIFIC VITAMIN B3 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 359. ASIA-PACIFIC VITAMIN B3 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 360. ASIA-PACIFIC VITAMIN B3 MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
TABLE 361. ASIA-PACIFIC VITAMIN B3 MARKET SIZE, BY POWDER, 2018-2032 (USD MILLION)
TABLE 362. ASIA-PACIFIC VITAMIN B3 MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 363. ASIA-PACIFIC VITAMIN B3 MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 364. ASIA-PACIFIC VITAMIN B3 MARKET SIZE, BY ANIMAL, 2018-2032 (USD MILLION)
TABLE 365. ASIA-PACIFIC VITAMIN B3 MARKET SIZE, BY PLANT, 2018-2032 (USD MILLION)
TABLE 366. ASIA-PACIFIC VITAMIN B3 MARKET SIZE, BY APPLICATION, 2018-2032 (U

Companies Mentioned

The key companies profiled in this Vitamin B3 market report include:
  • Adisseo France S.A.S.
  • Anhui Redpont Biotechnology Co., Ltd.
  • Archer-Daniels-Midland Company
  • BASF SE
  • Brother Enterprises Holding Co., Ltd.
  • Hefei TNJ Chemical Co., Ltd.
  • Jubilant Life Sciences Limited
  • Koninklijke DSM N.V.
  • Lonza Group AG
  • Shandong Binode Biopharma Co., Ltd.
  • Shandong Wosi Biotech Co., Ltd.
  • Zhejiang NHU Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages199
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 441.86 Million
Forecasted Market Value ( USD ) by 2032 $ 606.28 Million
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Vitamin B3 Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Vitamin B3 Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 93 Pages
  • Global
From
Vitamin Ingredients Market - Global Forecast 2026-2032 - Product Image

Vitamin Ingredients Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Vitamins Market - Global Forecast 2026-2032 - Product Image

Vitamins Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Vitamin B Complex Ingredients Market 2025-2033 - Product Image

Vitamin B Complex Ingredients Market 2025-2033

  • Report
  • 149 Pages
  • Global
From
Vitamin Ingredients Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Vitamin Ingredients Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 235 Pages
  • Global
From

About the Vitamin Market

Nicotinic Acid, also known as niacin, is a water-soluble vitamin found in a variety of foods, including meat, fish, eggs, and legumes. It is also available as a dietary supplement. Nicotinic Acid is an essential nutrient for the human body, and is used to help maintain healthy cholesterol levels, as well as to support energy production and nervous system health. It is also used to treat niacin deficiency, which can cause skin and digestive problems. Nicotinic Acid is a popular ingredient in many vitamins and dietary supplements, and is often combined with other vitamins and minerals to create a comprehensive supplement. It is also available in a variety of forms, including tablets, capsules, and powders. Some companies in the Nicotinic Acid market include Nature's Bounty, Solgar, Now Foods, and Puritan's Pride. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.